Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170362 · ClinicalTrials.gov registry record · NA
PRIME Care (PRecision Medicine In MEntal Health Care)
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,944
- Enrollment target
NCT03170362: Completed NA study, sponsored by VA Office of Research and Development.
NCT03170362 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,944 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170362, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,944 participants
- Enrollment target
Study Summary
The focus of this application is on the impact of providing depressed Veterans and their providers with the results of pharmacogenetic (PGx) testing for psychotropic medications. The project focuses on whether and how patients and providers use genetic test results given to them at the time an antidepressant is to be initiated to treat Major Depressive Disorder (MDD) and whether use of the test results improves patient outcomes. MDD is one of the most common conditions associated with military service and combat exposure, increases suicide risk, and worsens the course of common medical conditions, making it a leading cause of functional impairment and mortality. Validation of a PGx test to personalize the treatment of MDD represents an important opportunity to improve the healthcare of Veterans.
Interventions
- OTHER Pharmacogenetic Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,944 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170362
The ClinicalTrials.gov registry entry for NCT03170362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,944 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacogenetic Test is the first listed.
NCT03170362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03170362 about?
NCT03170362 is a clinical study titled "PRIME Care (PRecision Medicine In MEntal Health Care)". The focus of this application is on the impact of providing depressed Veterans and their providers with the results of pharmacogenetic (PGx) testing for psychotropic medications. The project focuses on whether and how patients and providers use genetic test results given to them at the time an antid...
What is the current status of trial NCT03170362?
This trial is currently completed. It is a NA study. The enrollment target is 1,944 participants. The study started on 2017-06-15. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT03170362?
The interventions under investigation include: Pharmacogenetic Test (OTHER).
Who is sponsoring clinical trial NCT03170362?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.